TIDMDVRG
Deepverge PLC
04 October 2022
4 October 2022
DeepVerge PLC
("DeepVerge" or "the Company" )
Labskin contract to develop revolutionary new approach to
testing for radiation exposure
Collaboration with team of experts to develop new standards to
protect military and civilians working or living near radiation
sources
Labskin, a DeepVerge (AIM:DVRG) business, announces its
selection by the Intelligence Advanced Research Projects Activity
("IARPA"), part of the US Office of the Director of National
Intelligence, to join a team of experts to develop new ways to
evaluate radiation exposure in civilians and military
personnel.
Labskin is a key member of a consortium selected to develop
these technologies in collaboration with a multidisciplinary team
of experts including professors from the University of Columbia in
New York, Georgetown University in Washington DC, the Georgia
Institute of Technology, scientists from the American Type Culture
Collection ("ATCC") and computer scientists and researchers from
ARETE Associates, a defence contractor specialising in sensing
solution and machine learning algorithms.
In a 3-year project worth $810k to the Company, starting
immediately, Labskin will help develop this technology into
minimally invasive testing for radiation for a programme known as
Targeted Evaluation of Ionizing Radiation Exposure ("TEI-REX") .
TEI-REX aims to develop novel approaches to evaluate organisms
exposed to low-dose ionising radiation. Labskin, coupled with Skin
Trust Club's expertise in skin research and microbiology, is
essential for the project.
The goal of the project is to develop a new biodosimetry
standard which could be applied to maintain the safety of military
and civilian populations working or living in close proximity to
ionizing radiation sources, such as: nuclear plants, nuclear
vessels, ammunition, etc. Labskin's contribution is the creation of
a simple non-invasive swab test to collect signatures from the skin
surface that allows machine learning algorithms to detect and
quantify the impact of any amount of radiation exposure on the skin
microbiome.
David Caballero-Lima, Chief Scientist, Labskin commented:
"This is a unique opportunity to revolutionise the way we test
for radiation exposure. Labskin and Skin Trust Club are at the
forefront of an increasing number of cutting edge technologies that
are changing our world. This technique can also be applied to
detect the impact of pollution or a variety of chemicals on the
environment. This type of testing could also be used to detect
exposure in complex ecological systems such as the soil, crops or
sediments."
Colin O'Sullivan, Chief Information Officer, Labskin
commented:
"We are committed to the success of this very exciting project.
The inclusion of artificial intelligence and the opportunity to
work with ARETE Associates, with their vast experience in complex
AI applications, will result in further advances in how AI can be
used in conjunction with our skin model at scale. This project
coincides with the expansion of our US labs in Delaware, which will
assist in the implementation of this large project. We believe our
proven ability to transition technology to the field with Skin
Trust Club will be invaluable as we progress this project ."
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners
Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
--------------------- -----------------
Turner Pope Investments Andy Thacker/James +44 (0) 20 3657
(TPI) Limited (Broker) Pope 0050
--------------------- -----------------
About DeepVerge
DeepVerge is an environmental and life science group of
companies that develops and applies AI and IoT technology to
analytical instruments for the analysis and identification of
bacteria, viruses and toxins. Utilizing artificial intelligent data
analytics to scientifically prove the impact of skincare product
claims on skin microbiome for most of the top 20 global cosmetic
company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water,
rivers, lakes and reservoirs.
Labskin (Life Science Division)
Labskin have been pioneering the development of laboratory grown
human skin platform for more than 15 years and is the only
commercially available lab-grown full thickness human skin model
that naturally mimics the skin's microbiome. With top 20 global
consumer health and skincare clients, thousands of industry tests,
the good and bad bacteria that naturally exists on human skin is
present on Labskin when testing skin care, cosmetics, health care,
drug delivery or wound care products. The Labskin test platform and
protocols help clients maintain an optimum real-world environment,
when testing their new ingredients and existing skincare products,
that shows the positive or negative impact on skin's natural
microflora.
Skin Trust Club
Skin Trust Club ( www.skintrustclub.com ), launched in 2021,
provides customized skincare routines derived from a home test kit,
lab tested and linked to local environment via a free smartphone
App that updates in real-time and identifies skincare products that
suit the subscribers unique skin microbiome. This revolutionizes
how you take care of your skin with your own skincare routine. The
Home Test Kit comprises a single swab that maps the skin microbiome
delivering a report that produces the most appropriate daily
skincare routine based on science, not guesswork. Using real-time
air pollution and weather data from the customer's location, the
Skin Trust App builds a complete picture of the skin microbiome and
the impact of local surroundings.
About Reach announcements
Reach is an investor communication service aimed at assisting
listed and unlisted (including AIM quoted) companies to distribute
media only / non-regulatory news releases such as marketing
messages, corporate and product information into the public domain.
An RNS Regulatory announcement is required to be notified under the
AIM Rules for Companies.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEADEDEAPAFFA
(END) Dow Jones Newswires
October 04, 2022 02:00 ET (06:00 GMT)
Integumen (LSE:SKIN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Integumen (LSE:SKIN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
